Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-07-07
1999-10-05
Mach, D. Margaret M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548558, 548559, C07D20710, A61K 3140
Patent
active
059625066
ABSTRACT:
Compounds of Formula I ##STR1## are disclosed as inhibitors having activity against the aspartyl proteases, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and Alzheimer's disease. In preferred compounds of Formula I, Y is an dialkoxyphosphonate, or .alpha.-hydroxyamide group and Z is an acyl or .alpha.-ketocarbamate functionality. Intermediates in the solid phase synthesis of compounds of Formula I, in which compounds are attached to a solid support, are also disclosed.
REFERENCES:
patent: 5565324 (1996-10-01), Still et al.
Rotella, D.P., "Solid Phase Synthesis of Olefin and Hydroxyethylene Peptidomimetics," Journal of the American Chemical Society, vol. 118, pp. 12246-12247 (1996).
Murphy, M.M. et al., "Combinatorial Organic Synthesis of Highly Functionalized Pyrrolidines . . . ," Journal of the American Chemical Society, vol. 117, No. 26, pp. 7029-7030 (1995).
Baldwin, J.J. et al., "Synthesis of a Small Molecule Combinatorial Library Encoded with Molecular Tags," Journal of the American Chemical Society, vol. 117, No. 20, pp. 5588-5589 (1995).
Wang, G.T. et al., "Synthetic Chemical Diversity: Solid Phase Synthesis of Libraries . . . " Journal of Medicinal Chemistry, vol. 38, No. 16, pp. 2995-3002 (1995).
Kick, E.K. et al., "Expedient Method for the Solid-Phase Synthesis of Aspartic Acid Protease Inhibitors . . . ," Journal of Medicinal Chemistry, vol. 38, No. 9, pp. 1427-1430 (1995).
Chem Abstr., vol. 124:29509; Ward, RA et al, "A total synthesis of the natural enantiomer of the gastroprotective natural products AI-77-B and amicoumacin C hydchloride." Tetrahedron 1995, 51(45), 12301-12318.
Chem Abstr., vol. 123:199384; Dee, MF et al., "Synthesis of alpha-hydroxy statine through a facially selective osmylation of a chiral .alpha.-amino crotonate." Bioorg.Med.Chem.Lett. 1995, 5(9), 949-952.
Chem Abstr., vol. 119:27906; Durgant, JM et al., "Naked sugar as synthesis intermediates. XXIII. Total synthesis of the gastroprotective substance AI-77-B and of analogs." Helv.Chim.Acta 1993, 76(1), 222-240.
Chem Abstr., vol. 117:251667; Evans, et al., "Total synthesis of (+)-calyculin A." J. Am.Chem.Soc. 1992, 114(24), 9434-9453.
Ward, RA, et al., "A total synthesis of AI-77-B." Tetrahedron Lett. 1992, 33(32), 3359-3362.
Chem Abstr., vol. 116:174631; Evans, DA, et al., "Asymmetric synthesis of calculin A. 2. The C26-C37 .gamma.-amino acid fragments." J. Org. Chem. 1992, 57(7), 1961-1963.
Chem Abstr., vol. 115:158817; Moran, EJ, et al., "Highly convergent approach to the synthesis of the epoxy-amide fragment of the azinoymycins." Tetrahedron Lett. 1991, 32(31), 3807-3810.
Chem Abstr., vol. 98:143174; Itoh, J, et al., "Chemical structures of amicoumacins produced by bacillus pumilus." Agric. Biol. Chem. 1982, 46(11), 2659-2565.
Carroll Carolyn DiIanni
Dolle, III Roland Ellwood
Herpin Timothee Felix
Shimshock Yvonne Class
M. Mach D. Margaret
Pharmacopeia Inc.
LandOfFree
Glycol and hydroxyphosphonate peptidomimetics as inhibitors of a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycol and hydroxyphosphonate peptidomimetics as inhibitors of a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycol and hydroxyphosphonate peptidomimetics as inhibitors of a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1172038